Intellectus Partners, LLC Collegium Pharmaceutical, Inc Transaction History

Intellectus Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $2,527 - $3,365	-171 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$14.16 - $24.3 $807 - $1,385	57 Added 50.0%	171 $3,000
Q2 2018 Aug 14, 2018	BUY	$21.79 - $28.29 $1,242 - $1,612	57 Added 100.0%	114 $3,000
Q1 2018 May 15, 2018	BUY	$18.15 - $29.21 $1,034 - $1,664	57 New	57 $1,000

247

37.6M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.1B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Intellectus Partners, LLC with notifications on news.